Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Yisheng Biopharma Receives IND Clearance from China NMPA to Initiate Clinical Trial of YS-ON-001 in the Treatment of Advanced Solid Tumors 2019-06-27 09:00
Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer 2019-06-26 21:47
Sirtex Medical reaches milestone 100,000th patient dose delivery of SIR-Spheres® Y-90 resin microspheres 2019-06-24 21:00
FDA Grants Orphan Drug Designation to XW Laboratories' XWL-008 for the Treatment of Patients with Narcolepsy 2019-06-24 17:00
Singapore Health Sciences Authority Approves Vosevi(R) (Sofosbuvir/ Velpatasvir/ Voxilaprevir) for Re-treatment of Adults with Chronic Hepatitis C Virus 2019-06-24 14:00
Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist 2019-06-24 10:00
European Medicines Agency Accepted First "China-Developed" Biosimilar - Henlius HLX02 Marketing Authorization Application for Review 2019-06-21 20:29
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing 2019-06-21 08:39
Gracell Data on Multi-center Investigation of FasT CAR-19 Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia 2019-06-21 08:00
Definiens & Targos Innovation: AI-powered multiplex IHC biomarker analytic solutions for precision medicine 2019-06-20 20:00
dMed Biopharmaceutical, a next generation CRO, announced the opening of its US Regulatory Affairs office in Washington DC to build a bridge for affordable innovative drugs for US patients 2019-06-19 23:59
Piramal Pharma Solutions recognized by Frost & Sullivan for its End-to-End Integrated Services Across the Entire Drug Development Life Cycle 2019-06-18 20:00
Seegene Establishes Brazilian Subsidiary 2019-06-18 19:00
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at 2019 ASCO and EHA Annual Meetings 2019-06-18 08:00
China National Medical Products Administration Approves Sinovant's Clinical Trial Application for Lefamulin 2019-06-14 09:00
Tessa Therapeutics and China-Singapore Guangzhou Knowledge City Form Landmark US$120 Million Joint Venture in China to Develop Innovative Cell Therapies for Cancer 2019-06-13 07:15
Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial 2019-06-12 02:45
Amcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer Packaging 2019-06-12 02:26
TauRx Recognized as a Technology Innovation Leader in the Neurodegenerative Disease Management Industry 2019-06-11 08:00
Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device 2019-06-10 21:00
1 189 190 191 192 193 241